$INNV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INNOVUS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INNOVUS PHARMACEUTICALS, INC.. Get notifications about new insider transactions in INNOVUS PHARMACEUTICALS, INC. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2020 | INNV | INNOVUS PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 0.00 | 200,637 | 201 | 0 | |
Feb 19 2020 | INNV | INNOVUS PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 8.40 | 431,489 | 3,624,508 | 0 | |
Feb 19 2020 | INNV | INNOVUS PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 7.35 | 431,489 | 3,171,444 | 0 | |
Feb 19 2020 | INNV | INNOVUS PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 15.75 | 76,190 | 1,199,993 | 0 | |
Feb 19 2020 | INNV | INNOVUS PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | J | 0.00 | 300,000 | 0 | 0 | 300 K to 0 (-100.00 %) |
Feb 19 2020 | INNV | INNOVUS PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 0.00 | 200,637 | 201 | 0 | |
Feb 19 2020 | INNV | INNOVUS PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 8.40 | 431,489 | 3,624,508 | 0 | |
Feb 19 2020 | INNV | INNOVUS PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 7.35 | 431,489 | 3,171,444 | 0 | |
Feb 19 2020 | INNV | INNOVUS PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Option Exercise | J | 15.75 | 76,190 | 1,199,993 | 0 | |
Feb 19 2020 | INNV | INNOVUS PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | J | 0.00 | 300,000 | 0 | 0 | 300 K to 0 (-100.00 %) |
Jan 07 2020 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Director | Option Exercise | A | 0.00 | 10,112 | 0 | 42,902 | |
Jan 07 2020 | INNV | INNOVUS PHARMACEUT ... | Nuhaily Dean | Director | Option Exercise | A | 0.00 | 6,742 | 0 | 19,327 | |
Jan 07 2020 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Director | Option Exercise | A | 0.00 | 6,742 | 0 | 38,104 | |
Oct 02 2019 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Director | Option Exercise | A | 0.00 | 4,286 | 0 | 32,790 | |
Oct 02 2019 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Director | Option Exercise | A | 0.00 | 2,858 | 0 | 31,362 | |
Oct 02 2019 | INNV | INNOVUS PHARMACEUT ... | Nuhaily Dean | Director | Option Exercise | A | 0.00 | 2,858 | 0 | 12,585 | |
Sep 18 2019 | INNV | INNOVUS PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 2.65 | 9,000 | 23,850 | 300,000 | 291 K to 300 K (+3.09 %) |
Sep 18 2019 | INNV | INNOVUS PHARMACEUT ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 2.48 | 9,183 | 22,774 | 291,000 | 281.8 K to 291 K (+3.26 %) |
Jul 03 2019 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Director | Option Exercise | A | 0.00 | 5,922 | 0 | 34,656 | |
Jul 03 2019 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Director | Option Exercise | A | 0.00 | 3,948 | 0 | 28,504 | |
Jul 03 2019 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Director | Option Exercise | A | 0.00 | 3,948 | 0 | 28,504 | |
Jul 03 2019 | INNV | INNOVUS PHARMACEUT ... | Nuhaily Dean | Director | Option Exercise | A | 0.00 | 3,948 | 0 | 9,727 | |
Apr 02 2019 | INNV | INNOVUS PHARMACEUT ... | Nuhaily Dean | Director | Option Exercise | A | 0.00 | 1,095 | 0 | 5,779 | |
Apr 02 2019 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Director | Option Exercise | A | 0.00 | 1,095 | 0 | 24,556 | |
Apr 02 2019 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Director | Option Exercise | A | 0.00 | 1,095 | 0 | 24,556 | |
Apr 02 2019 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Director | Option Exercise | A | 0.00 | 1,643 | 0 | 28,734 | |
Jan 04 2019 | INNV | INNOVUS PHARMACEUT ... | Nuhaily Dean | Director | Option Exercise | A | 0.00 | 89,552 | 0 | 455,646 | |
Jan 04 2019 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Director | Option Exercise | A | 0.00 | 89,552 | 0 | 2,461,314 | |
Jan 04 2019 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Director | Option Exercise | A | 0.00 | 89,552 | 0 | 2,461,314 | |
Jan 04 2019 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Director | Option Exercise | A | 0.00 | 89,552 | 0 | 2,842,387 | |
Oct 02 2018 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Director | Option Exercise | A | 0.00 | 50,000 | 0 | 2,371,762 | |
Oct 02 2018 | INNV | INNOVUS PHARMACEUT ... | Nuhaily Dean | Director | Option Exercise | A | 0.00 | 50,000 | 0 | 366,094 | |
Oct 02 2018 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Director | Option Exercise | A | 0.00 | 50,000 | 0 | 2,371,762 | |
Oct 02 2018 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Director | Option Exercise | A | 0.00 | 50,000 | 0 | 2,752,835 | |
Jul 19 2018 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 54,545 | 0 | 2,321,762 | ||
Jul 19 2018 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 54,545 | 0 | 2,321,762 | ||
Jul 19 2018 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 54,545 | 0 | 2,702,835 | ||
Apr 06 2018 | INNV | INNOVUS PHARMACEUT ... | Berholtz Randy | EVP, CORPORATE DEVE ... | Option Exercise | A | 0.00 | 1,000,000 | 0 | 3,675,000 | |
Apr 03 2018 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 49,059 | 0 | 2,648,290 | ||
Apr 03 2018 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 49,059 | 0 | 2,267,217 | ||
Apr 03 2018 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 49,059 | 0 | 2,267,217 | ||
Feb 27 2018 | INNV | INNOVUS PHARMACEUT ... | Gutierrez Rauly | VICE PRESIDENT, FIN ... | Option Exercise | A | 0.00 | 500,000 | 0 | 2,250,000 | |
Feb 27 2018 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 500,000 | 0 | 2,599,231 | ||
Feb 27 2018 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 71,856 | 0 | 2,099,231 | ||
Feb 27 2018 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 500,000 | 0 | 2,218,158 | ||
Feb 27 2018 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 35,928 | 0 | 1,718,158 | ||
Feb 27 2018 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 500,000 | 0 | 2,218,158 | ||
Feb 27 2018 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 35,928 | 0 | 1,718,158 | ||
Feb 27 2018 | INNV | INNOVUS PHARMACEUT ... | Berholtz Randy | EVP, CORPORATE DEVE ... | Option Exercise | A | 0.00 | 500,000 | 0 | 2,675,000 | |
Nov 27 2017 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Buy | P | 0.10 | 5,000 | 488 | 100,000 | 95 K to 100 K (+5.26 %) | |
Nov 27 2017 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Buy | P | 0.09 | 5,000 | 470 | 95,000 | 90 K to 95 K (+5.56 %) | |
Nov 27 2017 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Buy | P | 0.09 | 90,000 | 8,334 | 90,000 | 0 to 90 K | |
Nov 27 2017 | INNV | INNOVUS PHARMACEUT ... | Berholtz Randy | EVP, CORPORATE DEVE ... | Buy | P | 0.10 | 2,000 | 191 | 16,880 | 14.9 K to 16.9 K (+13.44 %) |
Nov 27 2017 | INNV | INNOVUS PHARMACEUT ... | Berholtz Randy | EVP, CORPORATE DEVE ... | Buy | P | 0.10 | 4,990 | 483 | 14,880 | 9.9 K to 14.9 K (+50.46 %) |
Nov 27 2017 | INNV | INNOVUS PHARMACEUT ... | Berholtz Randy | EVP, CORPORATE DEVE ... | Buy | P | 0.10 | 4,900 | 474 | 9,890 | 5 K to 9.9 K (+98.20 %) |
Nov 27 2017 | INNV | INNOVUS PHARMACEUT ... | Berholtz Randy | EVP, CORPORATE DEVE ... | Buy | P | 0.10 | 4,990 | 483 | 4,990 | 0 to 5 K |
Oct 02 2017 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 32,967 | 0 | 1,682,230 | ||
Oct 02 2017 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 32,967 | 0 | 1,682,230 | ||
Oct 02 2017 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 65,934 | 0 | 2,027,375 | ||
Jul 03 2017 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 26,643 | 0 | 1,649,263 | ||
Jul 03 2017 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 26,643 | 0 | 1,649,263 | ||
Jul 03 2017 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 53,286 | 0 | 1,961,441 | ||
Apr 03 2017 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 27,523 | 0 | 1,622,620 | ||
Apr 03 2017 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 27,523 | 0 | 1,622,620 | ||
Apr 03 2017 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 55,046 | 0 | 1,908,155 | ||
Jan 09 2017 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 30,227 | 0 | 1,853,109 | ||
Jan 09 2017 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 15,114 | 0 | 1,595,097 | ||
Jan 09 2017 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 15,114 | 0 | 1,595,097 | ||
Dec 02 2016 | INNV | INNOVUS PHARMACEUT ... | Novalere Holdings, LLC | 10% Owner | Buy | J | 0.00 | 12,808,796 | 0 | 25,617,592 | 12.8 M to 25.6 M (+100.00 %) |
Nov 21 2016 | INNV | INNOVUS PHARMACEUT ... | Damaj Bassam | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.00 | 2,000,000 | 0 | 7,875,000 | |
Nov 21 2016 | INNV | INNOVUS PHARMACEUT ... | HOFFMAN ROBERT | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.00 | 2,500,000 | 0 | 2,500,000 | |
Nov 21 2016 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 416,667 | 0 | 1,024,271 | ||
Nov 21 2016 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 11,538 | 0 | 607,604 | ||
Nov 21 2016 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 416,667 | 0 | 1,580,937 | ||
Nov 21 2016 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 11,538 | 0 | 1,164,270 | ||
Nov 21 2016 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 416,667 | 0 | 1,215,208 | ||
Nov 21 2016 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 23,076 | 0 | 798,541 | ||
Jul 15 2016 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 13,825 | 0 | 1,152,732 | ||
Jul 15 2016 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 44,709 | 0 | 1,138,907 | ||
Jul 15 2016 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 44,709 | 0 | 596,066 | ||
Jul 15 2016 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 44,709 | 0 | 582,241 | ||
Jul 15 2016 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 27,650 | 0 | 775,465 | ||
Jul 15 2016 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 89,419 | 0 | 747,815 | ||
Feb 02 2016 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 416,667 | 0 | 1,094,198 | ||
Feb 02 2016 | INNV | INNOVUS PHARMACEUT ... | Damaj Bassam | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.00 | 4,000,000 | 0 | 5,875,000 | |
Feb 02 2016 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 416,667 | 0 | 658,396 | ||
Feb 02 2016 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 416,667 | 0 | 537,532 | ||
Jan 06 2016 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 42,857 | 0 | 120,865 | ||
Jan 06 2016 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 85,714 | 0 | 241,729 | ||
Jan 05 2016 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 42,857 | 0 | 120,865 | ||
Dec 31 2015 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Gift | G | 0.00 | 2,949,145 | 0 | 0 | 2.9 M to 0 (-100.00 %) | |
Oct 02 2015 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 63,158 | 0 | 156,015 | ||
Oct 02 2015 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 31,579 | 0 | 78,008 | ||
Oct 02 2015 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 31,579 | 0 | 78,008 | ||
Jul 07 2015 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 25,000 | 0 | 46,429 | ||
Jul 07 2015 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 25,000 | 0 | 46,429 | ||
Jul 07 2015 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 50,000 | 0 | 92,857 | ||
Jun 29 2015 | INNV | INNOVUS PHARMACEUT ... | Damaj Bassam | PRESIDENT AND CEO | Grant | A | 0.12 | 50 | 6 | 6,852,322 | 6.9 M to 6.9 M (0.00 %) |
Apr 03 2015 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 21,429 | 0 | 21,429 | ||
Apr 03 2015 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 21,429 | 0 | 21,429 | ||
Apr 03 2015 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 42,857 | 0 | 42,857 | ||
Apr 01 2015 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Option Exercise | A | 0.00 | 500,000 | 0 | 500,000 | ||
Apr 01 2015 | INNV | INNOVUS PHARMACEUT ... | Damaj Bassam | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.00 | 4,500,000 | 0 | 4,500,000 | |
Apr 01 2015 | INNV | INNOVUS PHARMACEUT ... | DILLEN LYNNETTE | EVP, CFO | Option Exercise | A | 0.00 | 2,570,000 | 0 | 2,570,000 | |
Apr 01 2015 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Option Exercise | A | 0.00 | 500,000 | 0 | 500,000 | ||
Apr 01 2015 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Option Exercise | A | 0.00 | 500,000 | 0 | 500,000 | ||
Jan 23 2015 | INNV | INNOVUS PHARMACEUT ... | DILLEN LYNNETTE | EVP, CFO | Option Exercise | P | 0.30 | 250,000 | 75,000 | 250,000 | |
Jan 06 2015 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Grant | A | 0.00 | 18,750 | 0 | 474,483 | 455.7 K to 474.5 K (+4.11 %) | |
Jan 06 2015 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Grant | A | 0.00 | 37,500 | 0 | 1,826,284 | 1.8 M to 1.8 M (+2.10 %) | |
Jan 06 2015 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Grant | A | 0.00 | 18,750 | 0 | 901,219 | 882.5 K to 901.2 K (+2.12 %) | |
Dec 22 2014 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Gift | G | 0.00 | 135,000 | 0 | 882,469 | 1 M to 882.5 K (-13.27 %) | |
Oct 03 2014 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Grant | A | 0.00 | 16,216 | 0 | 1,788,784 | 1.8 M to 1.8 M (+0.91 %) | |
Oct 03 2014 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Grant | A | 0.00 | 8,108 | 0 | 1,017,469 | 1 M to 1 M (+0.80 %) | |
Oct 03 2014 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Grant | A | 0.00 | 8,108 | 0 | 455,733 | 447.6 K to 455.7 K (+1.81 %) | |
Jul 03 2014 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Director | Grant | A | 0.00 | 22,222 | 0 | 1,772,568 | 1.8 M to 1.8 M (+1.27 %) |
Jul 03 2014 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Director | Grant | A | 0.00 | 11,111 | 0 | 447,625 | 436.5 K to 447.6 K (+2.55 %) |
Jul 03 2014 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Director | Grant | A | 0.00 | 11,111 | 0 | 1,009,361 | 998.3 K to 1 M (+1.11 %) |
Apr 02 2014 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Director | Grant | A | 0.00 | 7,317 | 0 | 998,246 | 990.9 K to 998.2 K (+0.74 %) |
Apr 02 2014 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Director | Grant | A | 0.00 | 7,317 | 0 | 436,514 | 429.2 K to 436.5 K (+1.70 %) |
Apr 02 2014 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Director | Grant | A | 0.00 | 14,634 | 0 | 1,750,346 | 1.7 M to 1.8 M (+0.84 %) |
Feb 21 2014 | INNV | INNOVUS PHARMACEUT ... | Damaj Bassam | President and CEO | Buy | C | 0.00 | 1,190,411 | 0 | 1,708,265 | 517.9 K to 1.7 M (+229.87 %) |
Feb 20 2014 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Director | Buy | C | 0.00 | 146,014 | 0 | 990,929 | 844.9 K to 990.9 K (+17.28 %) |
Feb 20 2014 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Director | Buy | C | 0.00 | 190,304 | 0 | 1,735,712 | 1.5 M to 1.7 M (+12.31 %) |
Feb 20 2014 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Director | Buy | C | 0.00 | 37,964 | 0 | 1,545,408 | 1.5 M to 1.5 M (+2.52 %) |
Feb 20 2014 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Director | Buy | C | 0.00 | 190,304 | 0 | 1,735,712 | 1.5 M to 1.7 M (+12.31 %) |
Feb 20 2014 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Director | Buy | C | 0.00 | 37,964 | 0 | 1,545,408 | 1.5 M to 1.5 M (+2.52 %) |
Feb 20 2014 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Director | Buy | C | 0.00 | 14,601 | 0 | 429,197 | 414.6 K to 429.2 K (+3.52 %) |
Feb 10 2014 | INNV | INNOVUS PHARMACEUT ... | DILLEN LYNNETTE | EVP, CFO | Option Exercise | A | 0.00 | 600,000 | 0 | 600,000 | |
Feb 06 2014 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Director | Grant | A | 0.00 | 7,500 | 0 | 414,596 | 407.1 K to 414.6 K (+1.84 %) |
Feb 10 2014 | INNV | INNOVUS PHARMACEUT ... | Damaj Bassam | President and CEO | Option Exercise | A | 0.00 | 852,272 | 0 | 6,852,272 | |
Feb 10 2014 | INNV | INNOVUS PHARMACEUT ... | Damaj Bassam | President and CEO | Gift | G | 0.00 | 20,000 | 0 | 517,854 | 537.9 K to 517.9 K (-3.72 %) |
Feb 06 2014 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Director | Grant | A | 0.00 | 7,500 | 0 | 844,915 | 837.4 K to 844.9 K (+0.90 %) |
Feb 06 2014 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Director | Grant | A | 0.00 | 15,000 | 0 | 1,507,444 | 1.5 M to 1.5 M (+1.01 %) |
Oct 18 2013 | INNV | INNOVUS PHARMACEUT ... | MIRZA ZIAD | Director | Grant | A | 0.00 | 3,750 | 0 | 407,096 | 403.3 K to 407.1 K (+0.93 %) |
Oct 18 2013 | INNV | INNOVUS PHARMACEUT ... | LIU VIVIAN H | Director | Grant | A | 0.00 | 3,750 | 0 | 837,415 | 833.7 K to 837.4 K (+0.45 %) |
Oct 18 2013 | INNV | INNOVUS PHARMACEUT ... | ESBER HENRY JEMIL | Director | Grant | A | 0.00 | 3,750 | 0 | 1,492,444 | 1.5 M to 1.5 M (+0.25 %) |
Jun 14 2013 | INNV | INNOVUS PHARMACEUT ... | Damaj Bassam | President & CEO | Buy | P | 0.32 | 129,393 | 41,794 | 129,393 | 0 to 129.4 K |
Jun 14 2013 | INNV | INNOVUS PHARMACEUT ... | Damaj Bassam | President & CEO | Buy | P | 0.32 | 287,448 | 92,846 | 5,051,270 | 4.8 M to 5.1 M (+6.03 %) |
May 30 2013 | INNV | INNOVUS PHARMACEUT ... | BROWN MORGAN R | See remarks | Grant | A | 0.00 | 750,000 | 0 | 750,000 | 0 to 750 K |
Feb 19 2013 | INNV | INNOVUS PHARMACEUT ... | Damaj Bassam | President and CEO | Option Exercise | A | 0.00 | 6,000,000 | 0 | 6,000,000 | |
Feb 05 2013 | INNV | INNOVUS PHARMACEUT ... | Damaj Bassam | President and CEO | Buy | P | 0.48 | 250,406 | 118,993 | 250,406 | 0 to 250.4 K |
Page: 1